The National Institute of Allergy and Infectious Diseases (NIAID) requires one Varian TrueBeam Edge Radiotherapy Accelerator with associated trade-in, removal/disposal of existing equipment, TPS Eclipse licenses, and implementation services. The acquisition is a brand-name restricted, full-and-open competition under simplified acquisition procedures, with award based on lowest price technically acceptable. No specific budget amount is stated, though there are currently no known cost constraints. Performance of services includes delivery and installation at 10 Center Drive, Bethesda, MD 20892. This firm-fixed-price purchase order is for a commercial product intended to replace an aging system to maintain uninterrupted patient treatments.